(Q40521728)

21 September 2017

title

Severe myoclonic epilepsy in infancy: toward an optimal treatment (English)

1 reference

21 September 2017

1 reference

1 reference

Berten Ceulemans

1

1 reference

21 September 2017

Marc Boel

2

1 reference

21 September 2017

Lieve Claes

3

1 reference

21 September 2017

Lina Dom

4

1 reference

21 September 2017

Herman Willekens

5

1 reference

21 September 2017

Paul Thiry

6

1 reference

21 September 2017

Lieven Lagae

7

1 reference

21 September 2017

publication date

1 July 2004

1 reference

Journal of Child Neurology

21 September 2017

published in

1 reference

21 September 2017

volume

19

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

516-521

1 reference

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Epidemiology of Severe Myoclonic Epilepsy of Infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Carbamazepine-exacerbated epilepsy in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Stiripentol: efficacy and tolerability in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Refractory grand mal seizures with onset during infancy including severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiologic and pharmacoeconomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Newer antiepileptic drugs: advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

When antiepileptic drugs aggravate epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Catastrophic epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Molecular basis of an inherited epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738040190070701

10.1177/08830738040190070701

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference